𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Second primary tumors in patients with oral cancer

✍ Scribed by Gina L. Day; William J. Blot


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
522 KB
Volume
70
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Background. Patients with cancer of the oral cavity and pharynx have been described to be particularly susceptible to the development of new cancers.

Methods. Using data collected during 1973-1987 by nine population-based cancer registries in the United States, the authors evaluated risks of second primary cancers among 21,371 patients in whom oral and pharyngeal cancers were diagnosed, Results. The rate of development of second tumors was 3.7% per year. The risk of a second primary cancer was 2.8 times greater than expected, with 20-fold excesses of second oral or esophageal cancers and 4-fold to 7-fold increases of respiratory cancers. Increased risks persisted unabated for cancers diagnosed 5 or more years after oral cancer, suggesting that the second cancers were new primary tumors and not misdiagnosed metastases. The increased risks of second primary tumors were found among both men and women and black and white patients; they were most prominent among patients who were 60 years or younger.

Conclusions. The exceptionally high rate of cancer recurrence among patients with oral cancer (exceeding that for all other cancers) points to the need for close medical surveillance. Special emphasis should be placed on advising patients to avoid or limit consumption of tobacco and alcohol, the main risk factors for oral and most second cancers. Cancer 1992; 70:14-19. Key words: second primary tumors, oral


πŸ“œ SIMILAR VOLUMES


Second primary tumors in patients with c
✍ Smita Bhatia; Lilian Estrada-Batres; Tamara Maryon; Monica Bogue; David Chu πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 81 KB πŸ‘ 2 views

Several studies report coexistent or subsequent primary tumors (SPT) among patients with malignant melanoma (MM), with the rate of incidence ranging from 1.5-20% depending on the sample size and the length and completeness of follow-up. ## METHODS. The authors followed a cohort of patients with c

Second primary oral and pharyngeal cance
✍ Fabio Levi; Van-Cong Te; Lalao Randimbison; Manuela Maspoli; Carlo La Vecchia πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 122 KB

## Abstract Patients diagnosed with oral and pharyngeal (OP) cancer have a substantial excess risk of second OP cancer, but risk quantification is still uncertain and scanty information is available on the absolute excess risk of second OP cancer. We considered the risk of second OP primary cancer

Second primary cancers in patients with
✍ Fabio Levi; Lalao Randimbison; Van-Cong Te; Carlo La Vecchia πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 2 views

There are only limited population-based data available regarding the risk of developing a second cancer after a diagnosis of lung carcinoma. ## METHODS. Data collected from the Cancer Registry of the Swiss Canton of Vaud (comprised of approximately 600,000 inhabitants) were used to estimate the i

Second primary malignancies among patien
✍ Jianguang Ji; Kari Hemminki πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 87 KB

## Abstract Survival from soft tissue tumors (STTs) has been improved because of the successful treatment. One of the late sequelae in STT survivors is the development of a second malignancy. The present study aimed at quantifying risks for second malignancies in patients with STTs, and risks for s

Second primary head and neck tumor risk
✍ Camille C. Rose Ragin; Emanuela Taioli πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 225 KB πŸ‘ 2 views

## Abstract ## Background. Human papillomavirus (HPV) causes >99% of cervical carcinomas and is associated with approximately 25% of head and neck squamous cell carcinomas (HNSCCs). The role of HPV infection in HNSCC development after a first diagnosis of cervical cancer is unknown. ## Methods.